P&F Program

磷

• 批准号: 10016278
• 负责人: TOM A ELASY
• 金额: $ 9.62万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2022-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10016278
• 关键词: Applications Grants; Award; Behavior Therapy; Data; Diabetes Mellitus; Doctor of Medicine; Doctor of Philosophy; Eligibility Determination; Ensure; Expenditure; Faculty; Feasibility Studies; Funding; Funding Mechanisms; Grant; Guidelines; K-Series Research Career Programs; Lead; Letters; Measurement; Peer Review Grants; Pilot Projects; Research; Research Personnel; Research Project Grants; Research Support; Secure; Services; Structure; Technology; Testing; Time; Translational Research; Translations; United States National Institutes of Health; Update; Writing; base; design; instructor; member; programs; web site; Applications Grants; Award; Behavior Therapy; Data; Diabetes Mellitus; Doctor of Medicine; Doctor of Philosophy; Eligibility Determination; Ensure; Expenditure; Faculty; Feasibility Studies; Funding; Funding Mechanisms; Grant; Guidelines; K-Series Research Career Programs; Lead; Letters; Measurement; Peer Review Grants; Pilot Projects; Research; Research Personnel; Research Project Grants; Research Support; Secure; Services; Structure; Technology; Testing; Time; Translational Research; Translations; United States National Institutes of Health; Update; Writing; base; design; instructor; member; programs; web site

This P&F program has been highly successful over the first five years of funding of this CDTR. Eight investigators have been funded at $30,000/year for two years (total of $60,000 per investigator). In general, year one of funding has come from the CDTR while year two has come from a combination of philanthropy or shared expenditures with Vanderbilt's CTSA (see letter of support from Gordon Bernard, M.D., director of Vanderbilt's CTSA). Four investigators have already received either a K award or a DP3 award and a fifth awardee has secured a RO1 (two P&F recipients have pending K applications at the time of this writing – the results of which will be updated on our website (https://labnodes.vanderbilt.edu/cdtr). Our R01 recipient (Chandra Osborn, Ph.D.) who received a K award will lead a new core (Behavioral Intervention Technologies and Services Core) that reflects both her research focus as well as research base demands. Translation core investigators support both the design (structured statistical and measurement support pre-submission), implementation and analysis of the P&F grants. Vanderbilt CDTR proposes continuation of support for Pilot and Feasibility (P&F) funding for type II translation research in diabetes through it's Administrative Core. These funds are used for: 1) new investigators; 2) established investigators from other fields who bring their research expertise to diabetes; or 3) investigators in diabetes research who wish to test a new idea. This funding mechanism provides support that will allow an investigator the opportunity to develop the pilot data that will serve as the basis for obtaining independent research support through conventional external, peer-reviewed granting mechanisms. Two P&F studies in any one year (one new and one continuation) are funded and the funding is not intended for large undertakings by established investigators for which it would be appropriate to submit separate research grant applications nor to support or supplement ongoing research. Currently applicants must be a member of the VUMC or Meharry faculty (Instructor or above) to submit a P&F proposal, and they must meet the NIH Eligibility Guidelines for P&F support.

在此CDTR的前五年中，该P＆F计划非常成功。八 调查人员的资金为每年30,000美元，为期两年（每位调查员总计60,000美元）。一般来说， 第一年的资金来自CDTR，而第二年则来自慈善事业或 与范德比尔特（Vanderbilt）的CTSA共享支出（请参阅M.D. Gordon Bernard的支持信， 范德比尔特的CTSA）。四名调查人员已经获得了K奖或DP3奖和第五奖 获奖者已获得RO1（两个P＆F收件人在撰写本文时都有待定的K申请 - 结果将在我们的网站（https://labnodes.vander.edu/cdtr）上更新。我们的R01收件人 （Chandra Osborn，Ph.D.）获得K奖的人将领导新的核心（行为干预技术 和服务核心），反映了她的研究重点以及研究基础的需求。翻译核心 研究人员支持设计（结构化统计和测量支持前提取）， 行合赠款的实施和分析。 Vanderbilt CDTR提案延续了对飞行员和可行性的支持（P＆F）II型翻译的资金 通过其行政核心研究糖尿病。这些资金用于：1）新调查人员； 2） 来自其他领域的研究人员将其研究专业知识带入糖尿病；或3）调查人员 希望测试新想法的糖尿病研究。这种资金机制提供了支持 调查人员有机会开发将作为获得独立的基础的试点数据 通过常规外部，同行评审的授予机制进行研究支持。两项p＆f研究 一年（一个新的和一个延续）是资助的，这笔资金并非用于大型企业的资金 已建立的调查人员适合提交单独的研究赠款申请或 支持或补充正在进行的研究。当前申请必须是VUMC或Meharry的成员 提交P＆F提案的教师（教师或以上），他们必须符合NIH资格指南 P＆F支持。